The possibility of cancer immune editing in gliomas. A critical review

Area of Science:

• Neuro-oncology
• Cancer Immunology
• Tumor Genomics

Background:

• The interplay between anti-tumoral immunity and cancer progression is complex.
• Immune editing is a model explaining how the immune system selects for cancer cells that evade immune surveillance.
• Gliomas and glioblastoma are aggressive brain tumors characterized by genetic heterogeneity, low antigenicity, and poor response to immunotherapy.

Purpose of the Study:

• To provide an overview of the relationship between glioma's immune suppressive features, anti-tumoral immunity, and cancer genomics.
• To critically discuss evidence suggestive of immune editing in glioma and glioblastoma.
• To explore alternative explanations for observed findings in brain tumor immune editing.

Main Methods:

• Literature review
• Critical analysis of existing evidence
• Discussion of cancer genomics and immunology in brain tumors

Main Results:

• Gliomas exhibit immune suppressive features that influence anti-tumoral immunity.
• Evidence for immune editing in gliomas is suggestive but requires critical evaluation.
• The genetic heterogeneity and immune microenvironment of gliomas present unique challenges.

Conclusions:

• Understanding the complex relationship between immunity, genomics, and immune editing is crucial for developing effective brain tumor therapies.
• Alternative explanations beyond immune editing may be necessary to fully comprehend tumor progression in gliomas.
• Further research is needed to elucidate the precise mechanisms governing immune system interactions in brain tumors.